BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24728102)

  • 1. IPF fibroblasts are desensitized to type I collagen matrix-induced cell death by suppressing low autophagy via aberrant Akt/mTOR kinases.
    Nho RS; Hergert P
    PLoS One; 2014; 9(4):e94616. PubMed ID: 24728102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxO3a (Forkhead Box O3a) deficiency protects Idiopathic Pulmonary Fibrosis (IPF) fibroblasts from type I polymerized collagen matrix-induced apoptosis via caveolin-1 (cav-1) and Fas.
    Nho RS; Peterson M; Hergert P; Henke CA
    PLoS One; 2013; 8(4):e61017. PubMed ID: 23580232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological alteration of FoxO3a activity promotes idiopathic pulmonary fibrosis fibroblast proliferation on type i collagen matrix.
    Nho RS; Hergert P; Kahm J; Jessurun J; Henke C
    Am J Pathol; 2011 Nov; 179(5):2420-30. PubMed ID: 21893017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced FoxO3a expression causes low autophagy in idiopathic pulmonary fibrosis fibroblasts on collagen matrices.
    Im J; Hergert P; Nho RS
    Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(6):L552-61. PubMed ID: 26186945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
    Im J; Kim K; Hergert P; Nho RS
    J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix.
    Nho RS; Im J; Ho YY; Hergert P
    Am J Physiol Lung Cell Mol Physiol; 2014 Oct; 307(8):L632-42. PubMed ID: 25172912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis.
    Xia H; Diebold D; Nho R; Perlman D; Kleidon J; Kahm J; Avdulov S; Peterson M; Nerva J; Bitterman P; Henke C
    J Exp Med; 2008 Jul; 205(7):1659-72. PubMed ID: 18541712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of PI3K/AKT/mTOR axis regulates fibroblast proliferation, apoptosis and autophagy play a vital role in triptolide-induced epidural fibrosis reduction.
    Dai J; Sun Y; Chen D; Zhang Y; Yan L; Li X; Wang J
    Eur J Pharmacol; 2019 Dec; 864():172724. PubMed ID: 31600493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis.
    Xia H; Khalil W; Kahm J; Jessurun J; Kleidon J; Henke CA
    Am J Pathol; 2010 Jun; 176(6):2626-37. PubMed ID: 20395445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 12. Duvelisib attenuates bleomycin-induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathway.
    Li X; Ma X; Miao Y; Zhang J; Xi B; Li W; Zhang Q; Chen L; Yang Y; Li H; Wei L; Zhou H; Yang C
    J Cell Mol Med; 2023 Feb; 27(3):422-434. PubMed ID: 36651446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eupatilin inhibits pulmonary fibrosis by activating Sestrin2/PI3K/Akt/mTOR dependent autophagy pathway.
    Gong H; Lyu X; Liu Y; Peng N; Tan S; Dong L; Zhang X
    Life Sci; 2023 Dec; 334():122218. PubMed ID: 37918625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin alleviates pulmonary fibrosis through PI3K/AKT/mTOR-mediated autophagy pathway.
    Peng J; Xiao X; Li S; Lyu X; Gong H; Tan S; Dong L; Sanders YY; Zhang X
    Exp Gerontol; 2023 Feb; 172():112085. PubMed ID: 36623738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragaloside IV inhibits idiopathic pulmonary fibrosis through activation of autophagy by miR-21-mediated PTEN/PI3K/AKT/mTOR pathway.
    Li T; Gao X; Jia R; Sun Y; Ding Y; Wang F; Wang Y
    Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):128-136. PubMed ID: 38430031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppression.
    Lu X; Fan Q; Xu L; Li L; Yue Y; Xu Y; Su Y; Zhang D; Wang L
    PLoS One; 2015; 10(2):e0117400. PubMed ID: 25689721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-β1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt.
    Giménez A; Duch P; Puig M; Gabasa M; Xaubet A; Alcaraz J
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29144435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Rho kinase inhibitor (Fasudil) suppresses TGF-β mediated autophagy in urethra fibroblasts to attenuate traumatic urethral stricture (TUS) through re-activating Akt/mTOR pathway: An in vitro study.
    Feng H; Huang X; Fu W; Dong X; Yang F; Li L; Chu L
    Life Sci; 2021 Feb; 267():118960. PubMed ID: 33373654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression.
    Liu MW; Su MX; Tang DY; Hao L; Xun XH; Huang YQ
    BMC Pulm Med; 2019 Feb; 19(1):35. PubMed ID: 30744607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carnosic acid induces autophagic cell death through inhibition of the Akt/mTOR pathway in human hepatoma cells.
    Gao Q; Liu H; Yao Y; Geng L; Zhang X; Jiang L; Shi B; Yang F
    J Appl Toxicol; 2015 May; 35(5):485-92. PubMed ID: 25178877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.